Navigation Links
AMPURE PURIFICATION SYSTEM

AMPure is a high recovery, SPRI-based PCR clean up system capable of purifying amplicons as small as 100bp. AMPure yields high quality PCR amplicons using a simple, three-step protocol requiring no centrifugation or filtration steps. The protocol can be easily automated or performed manually in both 96 and 384-well formats.

EFFICIENT PCR PURIFICATION
AMPure provides:

  • Efficient removal of unincorporated dNTPs, primers and salts
  • High recovery of small and large amplicons
  • High quality PCR amplicons


  • FLEXIBLE PURIFICATION
    AMPure is flexible enough to be performed in a variety of formats for an array of applications:
    PLATFORMS: APPLICATIONS:
  • 96-well
  • PCR Sequencing
  • 384-well
  • cDNA labeling
  • Fully automated
  • Rolling Circle Amplification
  • Manual





    EFFECTIVE CLEAN UP
    AMPure removes unincorporated primers, dNTPs and salts used during PCR amplification. These products can interfere with downstream applications. AMPure routinely has recovery rates greater than 90% for amplicons larger than 200bp and greater than 85% for smaller PCR amplicons, such as the 165bp fragment shown in Figure 2. HIGH PURITY HIGH PERFORMANCE
    AMPure-purified samples are ideal sequencing templates. The table below shows sequencing results from a single 976bp PCR template purified using AMPure or ExoSAP-IT. The average Phred20 read length and average pass rate for the AMPure-purified samples were 701 and 100% respectively. ExoSAP-IT, an alternative approach of inactivating polymerases and degrading unincorporated primers following PCR thermo-cycling, produces samples with lower purity due to the presence of salts and degraded enzymes and primers. Sequence results following ExoSAP-IT digestions are consistently inferior, with fewer Phred20 bases per read and lower pass rates. Figure 3 exhibits the superior sequencing performance attained using AMPure. RELIABLE RESULTS
    AMPure produces reliable recoveries of both large and small amplicons. Figure 4 shows two gels following AMPure purification of 967 bp and 165 bp PCR fragments. SUPERIOR PERFORMANCE
    AMPure demonstrates excellent recovery rates of both small and large amplicons while maintaining high sample purity. AMPure samples have little to no contamination as shown by the lack of smearing above the bands (Figure 5). In contrast, alternative purification products have decreased recovery rates and/or lower sample purity, which affect the performance of downstream applications such as sequencing.
    COMPLETE AMPURE AUTOMATION
    The lack of centrifugation and filtration steps allows AMPure protocols to be completely automated while maintaining superior performance. AMPure is fully compatible with most commonly used low, medium and high throughout liquid handling systems. Contact Agencourt for the most up-to-date list of supported platforms.

    AMPure has been successfully automated on the Biomek FX from Beckman Coulter in 96 and 384-well formats. (Photo courtesy of Beckman Coulter.)



    '"/>


  • Source:


    Page: All 1 2 3

    Related biology technology :

    1. COSMCPREP HIGH AND LOW COPY PLASMID PURIFICATION
    2. SPRINTPREP SINGLE STEP PLASMID PURIFICATION
    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:2/16/2017)... Feb. 16, 2017 UCHealth ( Aurora, ... LungDirect for pulmonary nodule patient management. In addition to ... a spot on the lung, UCHealth looks to improve ... data entry. Stephanie Brown, RN , ... nodule patients with an Excel spreadsheet, which was extremely ...
    (Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
    (Date:2/16/2017)... Feb. 16, 2017  Windtree Therapeutics, Inc. (Nasdaq: ... on developing aerosolized KL4 surfactant therapies for respiratory ... influenza study showed that aerosolized KL4 surfactant reduced ... well-established preclinical animal model. The Company believes that ... of evidence that supports the role of KL4 ...
    (Date:2/16/2017)... PHOENIX and NEW YORK ... announced the near completion of their $7M Series B ... on top of the $3.5M led by Mesa Verde ... of 2016.  These resources will be directed towards further ... Test, PCDx, a comprehensive genomic profiling test and expanding ...
    Breaking Biology Technology:
    (Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
    (Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
    (Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... billion by 2021 from $8.3 billion in 2016 at ... 2016 to 2021. Report Includes - An overview ... global market trends, with data from 2015 and 2016, ... 2021. - Segmentation of the market on the basis ...
    Breaking Biology News(10 mins):